Persistent Loss of Hepatitis B Virus Markers in Serum without Cellular Immunity by Combination of Peginterferon and Entecavir Therapy in Humanized Mice

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  2017-07-10

• Fields of study

  Medicine

• Identifiers
  DOI 10.1128/AAC.00725-17PMID 28696237PMCID PMC5571312
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pegylated Interferon Alfa-2b Add-on Treatment in Hepatitis B Virus Envelope Antigen-Positive Chronic Hepatitis B Patients Treated with Nucleos(t)ide Analogue: A Randomized, Controlled Trial (PEGON)

  2017cited by this paper
• A potent hepatitis B surface antigen response in subjects with inactive hepatitis B surface antigen carrier treated with pegylated‐interferon alpha

  2017cited by this paper
• A randomized clinical trial of peginterferon alpha‐2b with or without entecavir in patients with HBeAg‐negative chronic hepatitis B: Role of host and viral factors associated with treatment response

  2016cited by this paper
• Elimination of HCV via a non-ISG-mediated mechanism by vaniprevir and BMS-788329 combination therapy in human hepatocyte chimeric mice.

  2016cited by this paper
• Interferon Treatment for Hepatitis B.

  2016cited by this paper
• Combination of Tenofovir Disoproxil Fumarate and Peginterferon α-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B.

  2016cited by this paper
• Targeting hepatitis B virus cccDNA using CRISPR/Cas9.

  2015cited by this paper
• Adding pegylated interferon to entecavir for hepatitis B e antigen–positive chronic hepatitis B: A multicenter randomized trial (ARES study)

  2015cited by this paper
• HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B

  2015cited by this paper
• Transcription of Hepatitis B Virus Covalently Closed Circular DNA Is Regulated by CpG Methylation during Chronic Infection

  2014cited by this paper
• Specific and Nonhepatotoxic Degradation of Nuclear Hepatitis B Virus cccDNA

  2014cited by this paper
• Pegylated IFN-α regulates hepatic gene expression through transient Jak/STAT activation.

  2014cited by this paper
• Immune cell responses are not required to induce substantial hepatitis B virus antigen decline during pegylated interferon-alpha administration.

  2014cited by this paper
• Hepatitis B virus infection.

  2014cited by this paper
• Alpha-Interferon Suppresses Hepadnavirus Transcription by Altering Epigenetic Modification of cccDNA Minichromosomes

  2013cited by this paper
• Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients With liver cirrhosis

  2013cited by this paper
• Long‐term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection

  2013cited by this paper
• Impact of peginterferon alpha‐2b and entecavir hydrate combination therapy on persistent viral suppression in patients with chronic hepatitis B

  2013cited by this paper
• Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study.

  2013cited by this paper
• The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus.

  2013cited by this paper
• IFN-α inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome.

  2012cited by this paper
• Hepatitis B surface antigen quantification: why and how to use it in 2011 - a core group report.

  2011cited by this paper
• Peginterferon alpha-based therapy for chronic hepatitis B focusing on HBsAg clearance or seroconversion: a meta-analysis of controlled clinical trials

  2011cited by this paper
• Long‐term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B

  2010cited by this paper
• Hepatitis B virus (HBV) genotype determination by the COBAS AmpliPrep/COBAS TaqMan HBV Test, v2.0 in serum and plasma matrices.

  2009cited by this paper
• Dual effect of APOBEC3G on Hepatitis B virus.

  2007cited by this paper
• Hepatitis B viral DNA is methylated in liver tissues

  2007cited by this paper
• Peginterferon alpha‐2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B

  2006cited by this paper
• Interferon‐inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication

  2006cited by this paper
• Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients

  2006cited by this paper
• Hepatitis B virus replication is regulated by the acetylation status of hepatitis B virus cccDNA-bound H3 and H4 histones.

  2006cited by this paper
• Inhibition of Alpha Interferon Signaling by Hepatitis B Virus

  2006cited by this paper
• Infection of human hepatocyte chimeric mouse with genetically engineered hepatitis B virus

  2005cited by this paper
• Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B.

  2005cited by this paper
• Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial.

  2005cited by this paper
• Near completely humanized liver in mice shows human-type metabolic responses to drugs.

  2004cited by this paper
• Histological outcome during long-term lamivudine therapy.

  2003cited by this paper
• Hepatitis C virus replication in mice with chimeric human livers

  2001cited by this paper
• Interferon treatment for hepatitis.

  1989cited by this paper
• Two distinct types of hepatitis in experimental hepatitis B virus infection.

  1980cited by this paper

• Comparison of Differentially Expressed Genes in Human Versus in Chimeric Mouse Livers Following HBV Infection

  2025cites this paper
• Alteration of Gene Expression After Entecavir and Pegylated Interferon Therapy in HBV-Infected Chimeric Mouse Liver

  2024cites this paper
• Interferon alpha induces a stronger antiviral effect than interferon lambda in HBV/HDV infected humanized mice

  2024influential citation
• Lipid nanoparticle-encapsulated DOCK11-siRNA efficiently reduces hepatitis B virus cccDNA level in infected mice

  2024cites this paper
• HBV with precore and basal core promoter mutations exhibits a high replication phenotype and causes ER stress-mediated cell death in humanized liver chimeric mice

  2023cites this paper
• An extracellular humanized IFNAR immunocompetent mouse model for analyses of human interferon alpha and subtypes

  2023cites this paper
• Humanized Mice for Infectious and Neurodegenerative disorders

  2021cites this paper
• Understanding the antiviral effects of RNAi-based therapy in HBeAg-positive chronic hepatitis B infection

  2021cites this paper
• Understanding Hepatitis B Virus Dynamics and the Antiviral Effect of Interferon Alpha Treatment in Humanized Chimeric Mice

  2021cites this paper
• Changes of cytokine levels and T cell surface molecules in patients with chronic hepatitis B and the association with functional cure

  2021cites this paper
• Highly Accurate, Specific And Sensitive Quantitation By Droplet Digital PCR Reveals The Stability of Intrahepatic Hepatitis B Virus cccDNA

  2021cites this paper
• Vitamin D signaling inhibits HBV activity by directly targeting the HBV core promoter

  2021cites this paper
• Mechanisms of DNA Methylation in Virus-Host Interaction in Hepatitis B Infection: Pathogenesis and Oncogenetic Properties

  2021cites this paper
• Are Humanized Mouse Models Useful for Basic Research of Hepatocarcinogenesis through Chronic Hepatitis B Virus Infection?

  2021cites this paper
• Understanding the antiviral effects of RNAi-based therapy on chronic hepatitis B infection

  2020cites this paper
• Comparison of intracellular responses between HBV genotype A and C infection in human hepatocyte chimeric mice

  2019cites this paper
• Anti-HBV activity of retinoid drugs in vitro versus in vivo.

  2019cites this paper
• Notch signaling facilitates hepatitis B virus covalently closed circular DNA transcription via cAMP response element-binding protein with E3 ubiquitin ligase-modulation

  2019cites this paper
• Regulation of the Hepatitis B virus replication and gene expression by the multi-functional protein TARDBP

  2019cites this paper
• When Hepatitis B Virus Meets Interferons

  2018cites this paper
• Epigenetic Regulation of Hepatitis B Virus Replication

  2018cites this paper